Articles published by Dermata Therapeutics
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/27717.jpg?v=0)
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/27717.jpg?v=0)
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/27717.jpg?v=0)
Dermata Therapeutics Provides Corporate Update and Reports First Quarter 2022 Financial Results
May 16, 2022
From Dermata Therapeutics
Via AccessWire
Exposures
Product Safety
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/27717.jpg?v=0)
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/27717.jpg?v=0)
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/27717.jpg?v=0)
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/27717.jpg?v=0)
Dermata Therapeutics to Participate in the 2022 Maxim Group Virtual Growth Conference
March 24, 2022
From Dermata Therapeutics
Via AccessWire
Tickers
DRMA
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/27717.jpg?v=0)
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/27717.jpg?v=0)
Dermata to Present at the H.C. Wainwright BioConnect Conference
January 05, 2022
From Dermata Therapeutics
Via AccessWire
Tickers
DRMA
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/27717.jpg?v=0)
Dermata Announces Positive Results from DMT410 Phase 1b Proof of Concept Study for Aesthetic Skin Conditions
November 19, 2021
From Dermata Therapeutics
Via AccessWire
Tickers
DRMA
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/27717.jpg?v=0)
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/27717.jpg?v=0)
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/27717.jpg?v=0)
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/27717.jpg?v=0)
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/27717.jpg?v=0)
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/27717.jpg)
Dermata Therapeutics, Inc. Reports Second Quarter 2021 Financial Results and Provides Corporate Update
September 27, 2021
From Dermata Therapeutics
Via AccessWire
Tickers
DRMA
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/27717.jpg)
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/27717.jpg)
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/27717.jpg)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.